CClaimWatch
Plaintiff counsel in 3 cases

Jeffrey Craig Block

Block & Leviton LLP

Address of record
260 Franklin Street, Suite 1860, Boston, MA 02110, 617-398-5600
Email
jeff@blockesq.com
Phone
(617) 398-5600
Fax
Fax (617)-507-6020

Contact details as filed with the court in the cases below.

4
Cases tracked
0 active · 4 settled
$71.7M
Plaintiff-side recovery
Disclosed settlement funds
Defense-side exposure
Resolved in settlements
4
Cases with values
of 4 tracked

Case history

Publicly tracked matters where this attorney is listed as counsel.

CounselSettled — claims closed

Spirit AeroSystems Securities Settlement

Spirit AeroSystems Holdings, Inc. is accused of making false or misleading statements regarding its publicly traded Class A common stock. The company has agreed to settle the securities litigation without admitting wrongdoing by paying $29.2 million to compensate shareholders who were injured by the alleged misstatements.

Settlement fund
$29.2M
Claim deadline
January 30, 2026
Represents
Michael D Joseph
Plaintiff counselSettled — accepting claims

Biogen Securities Litigation Settlement

Biogen Inc. investors allege securities violations related to the company's stock during a specific period. Biogen has settled this class action litigation for $18.9 million without admitting wrongdoing.

Settlement fund
$18.9M
Claim deadline
September 24, 2026
Represents
Oklahoma Firefighters Pension and Retirement System
Plaintiff counselSettled — claims closed

Tricida Securities Settlement

Tricida, Inc. and defendant Gerrit Klaerner are alleged to have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The defendant denies all claims and wrongdoing. The settlement resolves these allegations without admission of liability.

Settlement fund
$14.3M
Claim deadline
October 1, 2025
Represents
Michael Pardi, LEAD PLAINTIFF Jeffrey Fiore
Plaintiff counselSettled — claims closed

Boston Scientific Securities Litigation Settlement

Boston Scientific Corporation and certain executives allegedly violated federal securities laws by making false and misleading statements regarding Boston Scientific's Lotus Edge medical device. The company has settled the securities class action for $38.5 million in cash.

Settlement fund
$38.5M
Claim deadline
Represents
Mariano Errichiello

“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.